Inactive Instrument

Medidata Solutions, Inc.

US58471A1051

AllStripes Research Inc. announced that it has received $50 million in funding from Lux Capital Management, LLC, Spark Capital Partners, LLC, Maveron LLC, Jazz Venture Partners, L.P., Medidata Solutions, Inc., McKesson Ventures and other investors

August 23, 2021

On August 24, 2021, AllStripes Research Inc. closed the transaction. The company announced that it has received $50,000,000 in its series B round of funding led by returning investor Lux Capital Management, LLC. The transaction included participation from Jazz Venture Partners, L.P., Medidata Solutions, Inc., McKesson Ventures, returing investors Spark Capital Partners, LLC, Maveron LLC, individual investors Arif Nathoo and Leila Zegna.

The company received $45,199,734 from 18 investors pursuant to Regulation D.

Latest news about Medidata Solutions, Inc.

Medidata Announces New Experiences for Enhancing and Streamlining Clinical Data Workflows: Clinical Data Studio and Health Record Connect	Nov. 08	CI
Medidata and EDETEK Announce Partnership to Revolutionize Global Clinical Trial Data Management	Nov. 07	CI
Medidata Solutions, Inc. announced that it has received funding from TFS HealthScience	Nov. 05	CI
Medidata Next New York to Unveil New Vision for Life Sciences Innovation	Nov. 02	CI
Medidata Announces Expansion of Multi-Year Partnership with Catalyst Clinical Research for Oncology Trials	23-10-26	CI
Lambda Therapeutics Partners with Medidata to Automate and Streamline Data Management Processes for Greater Clinical Trial Efficiency	23-04-19	CI
Allucent Expands Use of Medidata Clinical Cloud to Accelerate New Drug Development for Unmet Patient Needs	23-03-07	CI
Medidata Launches New myMedidata Native App to Expedite Study Start Up and Improve Patient Experience	22-12-06	CI
Aural Analytics, Inc. Partners with Medidata and Its Sensor Cloud Network	22-07-21	CI
Medidata Launches New Clinical Operations Technologies to Address Critical Issues in Clinical Trial Oversight	22-06-27	CI
MMS Holdings Announces Partnership with Medidata to Provide Medidata’s Advanced Rave EDC and Decentralized Clinical Trial Solutions to Sponsors	22-06-07	CI
Ergomed Rare Disease Innovation Center to Leverage Medidata Patient Cloud, Intelligent Trials Technologies, and Synthetic Control Arm to Advance New Treatments	22-05-05	CI
Plus Therapeutics, Inc. Expands Partnership with and Medidata	22-04-05	CI
Labcorp Renews Strategic Partnership with Medidata to Provide Suite of Clinical Trial Technologies and Services	22-03-31	CI
Circuit Clinical Solutions Inc. announced that it has received $29 million in funding from a group of investors	22-03-15	CI
Plus Therapeutics, Inc. Partners with Medidata to Apply Innovative Synthetic Control Arm Solution to Accelerate Brain Cancer Clinical Trial	22-02-22	CI
Parexel Extends Strategic Partnership with Medidata to Enhance Delivery of Decentralized Clinical Trials	22-02-04	CI
Circuit Clinical Solutions Inc. announced that it has received $27 million in funding from Medidata Solutions, Inc. and other investors	22-01-25	CI
TD2 Partners with Medidata to Enhance its Clinical Operations and Accelerate Clinical Trials	21-10-14	CI
Circuit Clinical Solutions Inc. announced a financing transaction	21-10-07	CI
Medidata Launches Medidata Link, the First Centralized Technology Solution to Connect and Analyze Patient-Level Clinical Trial Data and Real-World Data	21-10-07	CI
Medidata Launches Groundbreaking Sensor Cloud Network to Connect Digital Health Innovators	21-10-06	CI
Rho Selects Medidata’s Decentralized Clinical Trial Capabilities for Patient-Focused Approach to New Drug Development	21-10-05	CI
Medidata Solutions, Inc. Names Rama Kondru and Sastry Chilukuri as Co-CEOs	21-09-27	CI
Labcorp Selects Medidata’s Sensor Cloud to Expand Decentralized Clinical Trial Capabilities	21-09-13	CI

Chart Medidata Solutions, Inc.

Duration

Period

More charts

Company Profile

Medidata Solutions Inc. (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company's plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments. Study Design Optimization enables customers to gain visibility into the impact of protocol elements on resource and trial endpoints. Grants Manager compares specific industry benchmarks and analytics, using industry's database of negotiated procedure costs, to support appropriate grants to investigator sites and automated negotiations with multiple investigator sites. Payments enables customers to establish a global investigator payment strategy and process to automate payment calculation, distribution and reporting, including tax and currency exchange calculations.

Sector

IT Services & Consulting

More about the company

Sector Other IT Services & Consulting

	1st Jan change	Capi.
ACCENTURE PLC	-10.65%	197B
IBM	+12.56%	169B
TATA CONSULTANCY SERVICES LTD.	+1.61%	166B
AUTOMATIC DATA PROCESSING, INC.	+5.85%	101B
RELX PLC	+5.77%	76.87B
CROWDSTRIKE HOLDINGS, INC.	+16.57%	71.98B
INFOSYS LIMITED	-6.78%	71.09B
SNOWFLAKE INC.	-22.12%	51.76B
HCL TECHNOLOGIES LIMITED	+2.65%	48.08B

Other IT Services & Consulting